| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.0096 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |